Cardiovascular complications of diabetes: role of non-coding RNAs in the crosstalk between immune and cardiovascular systems

Fecha de publicación: 24/05/2023 Fecha Ahead of Print: 24/05/2023

Autores de INCLIVA

Susana Novella Del Campo

Autor

Participantes ajenos a INCLIVA

Spinetti, G
Mutoli, M
Greco, S
Riccio, F
Ben-Aicha, S
Kenneweg, F
Jusic, A
de Gonzalo-Calvo, D
Nossent, AY
Kararigas, G
Thum, T
Emanueli, C
Devaux, Y
Martelli, F

Grupos y Plataformas de I+D+i

Grupo de Investigación en Células Endoteliales (LINCE)

Leading Researcher Co-IP

Susana Novella Del Campo

Abstract

Diabetes mellitus, a group of metabolic disorders characterized by high levels of blood glucose caused by insulin defect or impairment, is a major risk factor for cardiovascular diseases and related mortality. Patients with diabetes experience a state of chronic or intermittent hyperglycemia resulting in damage to the vasculature, leading to micro- and macro-vascular diseases. These conditions are associated with low-grade chronic inflammation and accelerated atherosclerosis. Several classes of leukocytes have been implicated in diabetic cardiovascular impairment. Although the molecular pathways through which diabetes elicits an inflammatory response have attracted significant attention, how they contribute to altering cardiovascular homeostasis is still incompletely understood. In this respect, non-coding RNAs (ncRNAs) are a still largely under-investigated class of transcripts that may play a fundamental role. This review article gathers the current knowledge on the function of ncRNAs in the crosstalk between immune and cardiovascular cells in the context of diabetic complications, highlighting the influence of biological sex in such mechanisms and exploring the potential role of ncRNAs as biomarkers and targets for treatments. The discussion closes by offering an overview of the ncRNAs involved in the increased cardiovascular risk suffered by patients with diabetes facing Sars-CoV-2 infection.